Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2023
TP53 Gain-of-Function Mutation Modulates the Immunosuppressive Microenvironment in Non-HPV-Associated Oral Squamous Cell Carcinoma, Yewen Shi, Xiaoyong Ren, Shaolong Cao, et al.
PRMT3-Mediated Arginine Methylation of IGF2BP1 Promotes Oxaliplatin Resistance in Liver Cancer, Yunxing Shi, Yi Niu, Yichuan Yuan, et al.
Sparse Tree-Based Clustering of Microbiome Data to Characterize Microbiome Heterogeneity in Pancreatic Cancer, Yushu Shi, Liangliang Zhang, Kim-Anh Do, et al.
Circulating Long Non-Coding RNAs As Novel Diagnostic Biomarkers for Alzheimer’s Disease (Ad): A Systematic Review and Meta-Analysis, Parnian Shobeiri, Sanam Alilou, Mehran Jaberinezhad, et al.
Peripheral Levels of the Brain-Derived Neurotrophic Factor in Coronary Artery Disease: A Systematic Review and Meta-Analysis, Parnian Shobeiri, Amir Hossein Behnoush, Amirmohammad Khalaji, et al.
Bayesian Feature Selection for Radiomics Using Reliability Metrics, Katherine Shoemaker, Rachel Ger, Laurence E Court, et al.
Protective Role of Colitis in Inflammatory Arthritis via Propionate-Producing Bacteroides in the Gut, Hoh-Jeong Shon, Yu-Mi Kim, Kyeong Seog Kim, et al.
Ultrasensitive Ngs Mrd Assessment in Ph+ All: Prognostic Impact and Correlation With Rt-Pcr for BCR::ABL1, Nicholas J Short, Elias Jabbour, Walid Macaron, et al.
A Phase 1/2 Study of Azacitidine, Venetoclax and Pevonedistat in Newly Diagnosed Secondary AML and in MDS or CMML After Failure of Hypomethylating Agents, Nicholas J Short, Muharrem Muftuoglu, Faustine Ong, et al.
A Phase 1/2 Study of Azacitidine, Venetoclax and Pevonedistat in Newly Diagnosed Secondary AML and in MDS or CMMLAfter Failure of Hypomethylating Agents, Nicholas J Short, Muharrem Muftuoglu, Faustine Ong, et al.
Treatment of Older Adults With FLT3-Mutated Aml: Emerging Paradigms and the Role of Frontline FLT3 Inhibitors, Nicholas J Short, Daniel Nguyen, and Farhad Ravandi
Impact of Type of Induction Therapy on Outcomes in Older Adults With AML After Allogeneic Stem Cell Transplantation, Nicholas J Short, Faustine Ong, Farhad Ravandi, et al.
An Update on the Management of Advanced Phase Chronic Myeloid Leukemia, Nicholas J Short, Jayastu Senapati, and Elias Jabbour
Drug-Like Small Molecules That Inhibit Expression of the Oncogenic MicroRNA-21, Matthew D Shortridge, Bhawna Chaubey, Huanyu J Zhang, et al.
Immunological Monitoring in Hepatitis C Virus Controlled Human Infection Model, Naglaa H Shoukry, Andrea L Cox, and Christopher M Walker
Author Correction: Multi-ancestry Genome-Wide Association Analyses Improve Resolution of Genes and Pathways Influencing Lung Function and Chronic Obstructive Pulmonary Disease Risk, Nick Shrine, Abril G Izquierdo, Jing Chen, et al.
Multi-ancestry Genome-Wide Association Analyses Improve Resolution of Genes and Pathways Influencing Lung Function and Chronic Obstructive Pulmonary Disease Risk, Nick Shrine, Abril G Izquierdo, Jing Chen, et al.
Genetic Determinants Underlying the Progressive Phenotype of β-Lactam/β-Lactamase Inhibitor Resistance in Escherichia coli, William C Shropshire, Hatim Amiji, Jordan Bremer, et al.
High-Level Ceftazidime/Avibactam Resistance in Escherichia coli Conferred by the Novel Plasmid-Mediated β-Lactamase Cmy-185 Variant, William C Shropshire, Bradley T Endres, Jovan Borjan, et al.
Temporal Dynamics of Genetically Heterogeneous Extended-Spectrum Cephalosporin-Resistant Escherichia coli Bloodstream Infections, William C Shropshire, Benjamin Strope, Selvalakshmi Selvaraj Anand, et al.
ETNK1 Mutation Occurs in a Wide Spectrum of Myeloid Neoplasms and Is Not Specific for Atypical Chronic Myeloid Leukemia, Wen Shuai, Zhuang Zuo, Nianyi Li, et al.
Hepatocellular Carcinoma With Hepatic Vein and Inferior Vena Cava Invasion, Akash Shukla and Abhinav Jain
The Lin28b/Wnt5a Axis Drives Pancreas Cancer Through Crosstalk Between Cancer Associated Fibroblasts and Tumor Epithelium, Zhaoqi Shu, Minghe Fan, Bo Tu, et al.
Blood-Based Transcriptomic Biomarkers Are Predictive of Neurodegeneration Rather Than Alzheimer's Disease, Artur Shvetcov, Shannon Thomson, Jessica Spathos, et al.
Immune and Pathologic Responses in Patients With Localized Prostate Cancer Who Received Daratumumab (Anti-CD38) or Edicotinib (Csf-1R Inhibitor), Bilal A Siddiqui, Brian F Chapin, Sonali Jindal, et al.